Status:
WITHDRAWN
Kinect Sensor in Cerebral Palsy Children: Phase 2.1
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
Warakorn Charoensuk
Apiphan Iamchaimongkol
Conditions:
Cerebral Palsy Children
Upper Extremity Problem
Eligibility:
All Genders
10-15 years
Phase:
NA
Brief Summary
There are 3 phases of the study. This registration is phase 2.1.This registration will conduct a pilot study in the cerebral palsy children.
Eligibility Criteria
Inclusion
- Spastic cerebral palsy aged 10-15 years
- Sufficient cognitive/attention capacity to understand basic instructions
- Can cooperate with the therapist for short period of time during training
- Manual Ability Classification System (MACS) 2-3
- Zancolli classification of the affected upper extremity was grade I-II.
- Give the informed consent
Exclusion
- Inability to understand the instruction and follow the task
- Severe comorbidities, visual or auditory impairment
- Had history of Botulinum toxin injection on the affected upper extremity for last 6 months or receive the injection during the study time
- Other treatment options planned on the affected upper extremity during the study time
- Wear daytime orthosis on the affected limb
- Zancolli classification of the affected hand was grade III.
- Got an epilepsy or convulsive condition
- Denied to give the informed consent or continue the study
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05338229
Start Date
June 1 2022
End Date
December 1 2022
Last Update
September 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.